PharmaCyte Biotech, Inc.
PMCB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001157075
No open-market purchases or sales by PharmaCyte Biotech, Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $586.2K in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in PharmaCyte Biotech, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- −3 vs. Q4 2023
- Shares held
- 978.3K
- −110.3K (−10.1%) vs. Q4 2023
- Total value
- $2.32M
- −$28.6K (−1.2%) vs. Q4 2023
- New holders
- 1
- 8 more added
- Sold out
- 4
- 10 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMCB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 32 | $586.2K |
| Q1 2026 | 36 | $643.2K |
| Q4 2025 | 30 | $712.0K |
| Q3 2025 | 25 | $419.9K |
| Q2 2025 | 25 | $632.1K |
| Q1 2025 | 26 | $709.9K |
| Q4 2024 | 23 | $934.3K |
| Q3 2024 | 29 | $1.58M |
| Q2 2024 | 32 | $2.02M |
| Q1 2024 | 33 | $2.32M |
| Q4 2023 | 36 | $2.35M |
| Q3 2023 | 34 | $2.40M |
| Q2 2023 | 32 | $3.47M |
| Q1 2023 | 33 | $10.2M |
| Q4 2022 | 34 | $9.93M |
| Q3 2022 | 33 | $12.0M |
| Q2 2022 | 35 | $8.79M |
| Q1 2022 | 28 | $8.83M |
| Q4 2021 | 30 | $8.68M |
| Q3 2021 | 24 | $4.42M |
| Q2 2021 | 5 | $5.43K |
| Q1 2021 | 5 | $8.68K |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding PharmaCyte Biotech, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Huntington National Bank | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 156 | $0 | 0.00% | −109−41.1% | Reduced |
| Carolina Wealth Advisors, LLC | 2 | $4 | 0.00% | 00.0% | Unchanged |
| Caldwell Sutter Capital, Inc. | 2 | $5 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 3 | $7 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 3 | $9 | 0.00% | −1−25.0% | Reduced |
| BFSG, LLC | 7 | $17 | 0.00% | +7 | New |
| UBS Group AG | 9 | $21 | 0.00% | −4−30.8% | Reduced |
| Sachetta, LLC | 14 | $31 | 0.00% | 00.0% | Unchanged |
| Highlander Capital Management, LLC | 14 | $33 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 18 | $43 | 0.00% | +6+50.0% | Added |
| Anchor Investment Management, LLC | 27 | $64 | 0.00% | 00.0% | Unchanged |
| Private Wealth Management Group, LLC | 42 | $100 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 54 | $128 | 0.00% | −8−12.9% | Reduced |
| Wells Fargo & Company | 55 | $130 | 0.00% | 00.0% | Unchanged |
| Kelly Financial Services LLC | 234 | $555 | 0.00% | 00.0% | Unchanged |
| Covestor Ltd | 226 | $1.00K | 0.00% | 00.0% | Unchanged |
| Aspire Private Capital, LLC | 800 | $1.90K | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 954 | $2.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,767 | $4.19K | 0.00% | +9+0.5% | Added |
| Tower Research Capital LLC (TRC) | 3,229 | $7.65K | 0.00% | +1,354+72.2% | Added |
| Acadian Asset Management LLC | 3,589 | $8.00K | 0.00% | −1,200−25.1% | Reduced |
| Citadel Advisors LLC | 8,561 | $20.3K | 0.00% | −20,057−70.1% | Reduced |
| Northern Trust Corp | 19,229 | $45.6K | 0.00% | −54−0.3% | Reduced |
| BlackRock Inc. | 21,104 | $50.0K | 0.00% | −7,665−26.6% | Reduced |
| Schonfeld Strategic Advisors LLC | 23,500 | $55.7K | 0.00% | +300+1.3% | Added |
| Dimensional Fund Advisors LP | 24,563 | $58.2K | 0.00% | −4,744−16.2% | Reduced |
| Susquehanna International Group, LLP | 41,188 | $97.6K | 0.00% | +19,160+87.0% | Added |
| Renaissance Technologies LLC | 43,800 | $104.0K | 0.00% | +5,700+15.0% | Added |
| Equitec Proprietary Markets, LLC | 82,727 | $196.1K | 0.35% | 00.0% | Unchanged |
| Vanguard Group Inc | 174,602 | $413.8K | 0.00% | +3,267+1.9% | Added |
| Geode Capital Management, LLC | 200,281 | $474.7K | 0.00% | −15,356−7.1% | Reduced |
| K2 Principal Fund, L.P. | 327,503 | $776.2K | 0.18% | +22,890+7.5% | Added |
| Sabby Management, LLC | 0 | $0 | 0.00% | −82,373−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −16,598−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −14,846−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −14−100.0% | Sold out |